Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Nov 24 | AXNX Axonics | Common Stock | Sale back to company | Dispose D | No | No | 71 | 14,944 | 1.06 mm | 0 |
15 Nov 24 | AXNX Axonics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 49.96 | 10,000 | 499.60 k | 0 |
15 Nov 24 | AXNX Axonics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 36.9 | 4,167 | 153.76 k | 0 |
7 Nov 24 | AXNX Axonics | Common Stock | Gift | Dispose G | No | No | 0 | 5,000 | 0.00 | 14,944 |
29 Jun 24 | ALKS Alkermes | Ordinary Shares | Payment of exercise | Dispose F | No | No | 24.1 | 1,465 | 35.31 k | 4,639 |
29 Jun 24 | ALKS Alkermes | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 6,104 | 0.00 | 6,104 |
29 Jun 24 | ALKS Alkermes | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 6,104 | 0.00 | 0 |
13 Jun 24 | LYRA Lyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 30,000 | 9.30 k | 30,000 |
31 May 24 | ALKS Alkermes | Non Qualified Stock Option Ordinary Shares | Grant | Acquire A | No | No | 23.4 | 17,492 | 409.31 k | 17,492 |
31 May 24 | ALKS Alkermes | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 8,013 | 0.00 | 8,013 |